Our results, based on analyses of available microarray data sets, demonstrated that expression levels of Pth1r in primary tumors were significantly lower than in healthy breast tissue and that tumor progression was often accompanied by a significant reduction in Pth1r levels. This evidence concerns the gene PTH1R and neoplasm.